Market closedNon-fractional

Heron Therapeutics/HRTX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Heron Therapeutics

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Ticker

HRTX

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

San Diego, United States

Employees

126

HRTX Metrics

BasicAdvanced
$417M
Market cap
-
P/E ratio
-$0.56
EPS
1.73
Beta
-
Dividend rate
$417M
1.73
2.466
1.815
-521.335
-530.625
-16.74%
-18.45%
358.23%
3.064
-12.31
-12.31
-9.05
16.05%
-58.24%
16.63%
-39.45%

What the Analysts think about HRTX

Analyst Ratings

Majority rating from 4 analysts.
Buy

HRTX Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-8.95% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$35M
1.17%
Net income
-$3.1M
-71.03%
Profit margin
-8.95%
-71.39%

HRTX Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 77.78%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.35
-$0.17
-$0.07
-$0.02
-
Expected
-$0.23
-$0.29
-$0.16
-$0.09
-$0.04
Surprise
49.96%
-41.88%
-57.23%
-77.78%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Heron Therapeutics stock?

Heron Therapeutics (HRTX) has a market cap of $417M as of July 06, 2024.

What is the P/E ratio for Heron Therapeutics stock?

The price to earnings (P/E) ratio for Heron Therapeutics (HRTX) stock is 0 as of July 06, 2024.

Does Heron Therapeutics stock pay dividends?

No, Heron Therapeutics (HRTX) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Heron Therapeutics dividend payment date?

Heron Therapeutics (HRTX) stock does not pay dividends to its shareholders.

What is the beta indicator for Heron Therapeutics?

Heron Therapeutics (HRTX) has a beta rating of 1.73. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Heron Therapeutics stock

Buy or sell Heron Therapeutics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing